Table 29:
Analysis | First-Tier NIPT, $ | Second-Tier NIPT, $ |
---|---|---|
Reference casea | 4,226,461 | 1,838,133 |
Scenario Analyses | ||
Increased uptake of first-tier NIPT | ||
80% | 4,836,005 | 1,838,133 |
90% | 5,343,235 | 1,838,133 |
100% | 5,824,888 | 1,838,133 |
Inclusion of sex chromosome aneuploidies in first-tier NIPT | 4,767,412a | 1,838,133 |
Inclusion of sex chromosome aneuploidies and 22q11.2 deletion in first-tier NIPT | 6,117,118b | 1,838,133 |
Varying price of NIPT | ||
$200 | 2,947,834 | 1,798,638 |
$300 | 3,608,681 | 1,821,276 |
$500 | 4,974,501 | 1,870,034 |
Funding first-tier NIPT for pregnant people 35–39 years old | 4,291,520 | 1,890,179 |
Abbreviation: NIPT, noninvasive prenatal testing.
Note: Some numbers may appear inexact due to rounding. All costs are in 2017 Canadian dollars.
Price of NIPT is $390.
Costs were based on the expected prevalence of sex chromosome aneuploidies and trisomies 21, 18, and 13.
Costs were based on an NIPT detection rate of 50% for 22q11.2 deletion.